CAXTON CORP
Latest 13F filing data - Q4 2025
Holdings (Top positions)
| Stock | Ticker | ||
|---|---|---|---|
 | CMPX | 29K | $158.39K |
 | IKT | 28K | $58.33K |
 | KYTX | 19K | $176.47K |
 | CNTX | 18K | $27.05K |
 | MNMD | 16K | $210.06K |
 | XFOR | 16K | $62.23K |
 | LXEO | 14K | $138.45K |
 | SABS | 11K | $39.37K |
 | SYRE | 9K | $292.19K |
 | BRK-B | 710 | $356.77K |
Compass Therapeutics, Inc.
CMPX
Shares Held
29K
Value
$158.39K
Inhibikase Therapeutics, Inc.
IKT
Shares Held
28K
Value
$58.33K
Kyverna Therapeutics, Inc.
KYTX
Shares Held
19K
Value
$176.47K
Context Therapeutics Inc.
CNTX
Shares Held
18K
Value
$27.05K
Mind Medicine (MindMed) Inc.
MNMD
Shares Held
16K
Value
$210.06K
X4 Pharmaceuticals, Inc.
XFOR
Shares Held
16K
Value
$62.23K
Lexeo Therapeutics, Inc. Common Stock
LXEO
Shares Held
14K
Value
$138.45K
SAB Biotherapeutics, Inc.
SABS
Shares Held
11K
Value
$39.37K
Spyre Therapeutics, Inc.
SYRE
Shares Held
9K
Value
$292.19K
Berkshire Hathaway Inc.
BRK-B
Shares Held
710
Value
$356.77K